Cited by 43Cancer survivorship and careCancer-related cognitive impairment studiesIntensive Care Unit Cognitive Disorders

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients

Park, Jin-Hee, Jung, Yong Sik, Jung, Young-Mi, Bae, Sun Hyoung·2019·Supportive Care in Cancer

Abstract

Purpose Cancer patients who underwent chemotherapy experience cognitive decline, which, in turn, negatively impacts quality of life (QoL). Depression is considered a psychological factor that is negatively associated with the QoL of cancer patients. However, the relationships among cognitive functioning, depression, and QoL in breast cancer patients are under-researched in the literature. The aim of this cross-sectional study was to identify the role of depression in the relationship between cognitive functioning and QoL among breast cancer patients.Methods One hundred thirty breast cancer patients who underwent primary treatment participated. Participants completed the Functional Assessment of Cancer Therapy-Cognitive Function version 3, the Montreal Cognitive Assessment, the Beck Depression Inventory-II, and the Functional Assessment of Cancer Therapy-Breast Scale. The data were analyzed using multiple regression according to Baron and Kenny's strategies and the Sobel test.Results Subjective and objective cognitive functioning and depression were statistically significant predictors of QoL in breast cancer patients. Depression played a partial mediating role in the relationship between objective cognitive functioning and QoL and between subjective cognitive functioning and QoL. Additionally, the Sobel test demonstrated that depression had a significant partial mediating effect between subjective cognitive functioning and QoL (Z = 4.91, p < 0.001) and between objective cognitive functioning and QoL (Z = 2.62, p = 0.009).Conclusions The findings indicated that depression could influence the association between cognitive functioning and QoL in breast cancer patients. Healthcare providers should develop an intervention focused on decreasing depression to evaluate the effectiveness of improving quality of life for breast cancer patients with cognitive dysfunction.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00520-018-4546-x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 2

  1. Wagner LI, Sweet J, Butt Z, Lai JS, Cella D (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy–cognitive function instrument. J Support Oncol 7:W32–W39
  2. Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory–II, 2nd edn. Psychological Corporation, San Antonio

Cited by

Sorted by citations

See all 43

Metadata

Authors
Park, J.-H., Jung, Y. S., Jung, Y.-M., & Bae, S. H.
Affiliations
  • Ajou University (KR)
  • Cheongju University (KR)
Corresponding author
Bae, Sun Hyoung
Venue
Supportive Care in Cancer
Published
2018-11-29
Volume
27
Issue
7
Pages
2707-2714
ISSN
  • 0941-4355 (ISSN-L)
  • 1433-7339
OpenAlex
W2902208011
Cited by
43
References
28
Citations by year
2026: 2 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 3
FWCI
1.22
Type
journal article
Language
en
Open access
closed
Locations
  • Supportive Care in Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • AJOU Open Repository (Ajou University) (submittedVersion)
Funders
Ajou University
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords
depression, cognitive decline, quality of life, breast cancer, chemotherapy, cognitive function, mediation, cancer-related cognitive impairment, breast cancer survivors
MeSH terms
Adult, Breast Neoplasms, Cross-Sectional Studies, Depression, Depressive Disorder, Female, Humans, Middle Aged, Quality of Life, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients. https://app.cochat.ai/papers/10.1007/s00520-018-4546-x
The paper
Park, J.-H., Jung, Y. S., Jung, Y.-M., & Bae, S. H. (2019). The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients. Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4546-x